All lobbying filings

ARNOLD & PORTER KAYE SCHOLER LLP

ARNOLD & PORTER KAYE SCHOLER LLP filed a Q3 report for UNICYCIVE THERAPEUTICS INC. on October 19, 2026, reporting $40,000 in lobbying income.

Lobbying for UNICYCIVE THERAPEUTICS INC. · Clinical-stage biopharmaceutical company focused on novel therapies for kidney disease.

All filings by ARNOLD & PORTER KAYE SCHOLER LLP · Everything UNICYCIVE THERAPEUTICS INC. has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 19, 2026

Income

$40,000

What the client paid this registrant for the period.

Client based in

California

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Issue related to kidney disease therapeutics.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.